Statins, which lower CRP levels and improve lipid profiles simultaneously, may offer dual benefits in preventing gallstones.[43] Similarly, GLP-1 agonists have been shown to enhance gallbladder evacuation in diabetic patients and may mitigate the risk associated with CTI.[44]. Here, CRP is linked to gallstones.